At 6.1% CAGR, Europe Non-Invasive Ventilation Masks Market is Projected to be Worth US$ 922.02 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Europe non-invasive ventilation masks market was valued at US$ 574.58 million in 2023 and is expected to reach US$ 922.02 million by 2031, registering a CAGR of 6.1% from 2023 to 2031. Increasing adoption of NIV masks and growing inclination towards home healthcare are among the critical factors attributed to drive the Europe non-invasive ventilation masks market growth.

Noninvasive ventilation masks are becoming increasingly popular and expanding market opportunities by spurring innovation. Earlier diagnosis and treatment are being made possible by growing awareness campaigns about respiratory disorders such as COPD, sleep apnea, and others. The increased prescription and usage of NIV masks for disease management results from greater awareness among patients and healthcare professionals. Thus, emerging awareness of early diagnosis is likely to drive the adoption of NIV masks and create significant opportunities in the market. The Noninvasive therapies are becoming widely known in these areas, owing to which the use of NIV masks is likely to continue to propel during the forecast period.

On the contrary, side effects associated with NIV masks hamper the growth of Europe non-invasive ventilation masks market.

By product, the Europe non-invasive ventilation masks market is bifurcated into noninvasive ventilation disposable mask and noninvasive ventilation reusable mask. The noninvasive ventilation disposable mask segment held 61.4% share of Europe non-invasive ventilation masks market share in 2023, amassing US$ 352.91 million. It is projected to garner US$ 554.56 million by 2031 to register 5.8% CAGR during 2023–2031.

In terms of application, the Europe non-invasive ventilation masks market is segmented into sleep apnea, chronic obstructive pulmonary disease, pneumonia, and others. The sleep apnea segment held 55.6% share of Europe non-invasive ventilation masks market share in 2023, amassing US$ 319.74 million. It is projected to garner US$ 521.77 million by 2031 to register 6.3% CAGR during 2023–2031.

Based on end user, the Europe non-invasive ventilation masks market is segmented into hospitals and clinics, home care, and others. The hospitals and clinics segment held 50.7% share of Europe non-invasive ventilation masks market share in 2023, amassing US$ 291.47 million. It is projected to garner US$ 475.96 million by 2031 to register 6.3% CAGR during 2023–2031.

Based on country, the Europe non-invasive ventilation masks market is categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 24.6% share of Europe non-invasive ventilation masks market in 2023. It was assessed at US$ 141.06 million in 2023 and is likely to hit US$ 233.35 million by 2031, registering a CAGR of 6.5% during 2023–2031.

Key players operating in the cosmetic preservatives market are Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar S.P.A.; Dragerwerk AG & Co KGaA; Fisher & Paykel Healthcare Corp Ltd; Hamilton Medical AG; Hangzhou Formed Medical Devices Co., Ltd; Intersurgical Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC ( AirLife); and SURU INTERNATIONAL PVT. LTD., among others.

• In May 2022: Air Liquide Healthcare launched ALNEST N1 Silent mask. Alnest N1 Silent and Alnest N1 are reusable nasal masks with calibrated exhalation orifices (vented) for adult patients (weighing more than 30 kg) undergoing non-invasive positive pressure ventilation therapy (NPPV) like CPAP or BiPAP.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com